These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 26273637)

  • 1. Network-Based Association Study of Obesity and Type 2 Diabetes with Gene Expression Profiles.
    Zhang S; Wang B; Shi J; Li J
    Biomed Res Int; 2015; 2015():619730. PubMed ID: 26273637
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MECHANISMS IN ENDOCRINOLOGY: Metabolic and inflammatory pathways on the pathogenesis of type 2 diabetes.
    Coope A; Torsoni AS; Velloso LA
    Eur J Endocrinol; 2016 May; 174(5):R175-87. PubMed ID: 26646937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extracting time-dependent obese-diabetic specific networks in hepatic proteome analysis.
    Midha MK; Tikoo K; Sinha N; Kaur S; Verma HN; Rao KV; Chatterjee S; Manivel V
    J Proteome Res; 2012 Dec; 11(12):6030-43. PubMed ID: 23050596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alterations of a Cellular Cholesterol Metabolism Network Are a Molecular Feature of Obesity-Related Type 2 Diabetes and Cardiovascular Disease.
    Ding J; Reynolds LM; Zeller T; Müller C; Lohman K; Nicklas BJ; Kritchevsky SB; Huang Z; de la Fuente A; Soranzo N; Settlage RE; Chuang CC; Howard T; Xu N; Goodarzi MO; Chen YD; Rotter JI; Siscovick DS; Parks JS; Murphy S; Jacobs DR; Post W; Tracy RP; Wild PS; Blankenberg S; Hoeschele I; Herrington D; McCall CE; Liu Y
    Diabetes; 2015 Oct; 64(10):3464-74. PubMed ID: 26153245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TLR3 and its roles in the pathogenesis of type 2 diabetes.
    Sepehri Z; Kiani Z; Javadian F; Akbar Nasiri A; Kohan F; Sepehrikia S; Javan Siamardi S; Aali H; Daneshvar H; Kennedy D
    Cell Mol Biol (Noisy-le-grand); 2015 Jun; 61(3):46-50. PubMed ID: 26081813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adaptive and maladaptive cortisol responses to pediatric obesity.
    Soros A; Zadik Z; Chalew S
    Med Hypotheses; 2008 Sep; 71(3):394-8. PubMed ID: 18547740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of differential proteomes associated with the development of type 2 diabetes in the Zucker rat model using the iTRAQ technique.
    Han D; Moon S; Kim H; Choi SE; Lee SJ; Park KS; Jun H; Kang Y; Kim Y
    J Proteome Res; 2011 Feb; 10(2):564-77. PubMed ID: 21117707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Age-related obesity and type 2 diabetes dysregulate neuronal associated genes and proteins in humans.
    Rahimi M; Vinciguerra M; Daghighi M; Özcan B; Akbarkhanzadeh V; Sheedfar F; Amini M; Mazza T; Pazienza V; Motazacker MM; Mahmoudi M; De Rooij FW; Sijbrands E; Peppelenbosch MP; Rezaee F
    Oncotarget; 2015 Oct; 6(30):29818-32. PubMed ID: 26337083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of DNA damage and mRNA/miRNA transcriptional expression profiles in hyperglycemic versus non-hyperglycemic patients with type 2 diabetes mellitus.
    Xavier DJ; Takahashi P; Evangelista AF; Foss-Freitas MC; Foss MC; Donadi EA; Passos GA; Sakamoto-Hojo ET
    Mutat Res; 2015 Jun; 776():98-110. PubMed ID: 26364207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deciphering the therapeutic mechanisms of Xiao-Ke-An in treatment of type 2 diabetes in mice by a Fangjiomics approach.
    Yang ZZ; Liu W; Zhang F; Li Z; Cheng YY
    Acta Pharmacol Sin; 2015 Jun; 36(6):699-707. PubMed ID: 25960133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary defects in lipolysis and insulin action in skeletal muscle cells from type 2 diabetic individuals.
    Kase ET; Feng YZ; Badin PM; Bakke SS; Laurens C; Coue M; Langin D; Gaster M; Thoresen GH; Rustan AC; Moro C
    Biochim Biophys Acta; 2015 Sep; 1851(9):1194-201. PubMed ID: 25819461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deciphering Signaling Pathway Networks to Understand the Molecular Mechanisms of Metformin Action.
    Sun J; Zhao M; Jia P; Wang L; Wu Y; Iverson C; Zhou Y; Bowton E; Roden DM; Denny JC; Aldrich MC; Xu H; Zhao Z
    PLoS Comput Biol; 2015 Jun; 11(6):e1004202. PubMed ID: 26083494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human BRS-3 receptor: functions/role in cell signaling pathways and glucose metabolism in obese or diabetic myocytes.
    Ramos-Álvarez I; Moreno-Villegas Z; Martín-Duce A; Sanz R; Aparicio C; Portal-Núñez S; Mantey SA; Jensen RT; González N
    Peptides; 2014 Jan; 51():91-9. PubMed ID: 24220502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Landscape of the relationship between type 2 diabetes and coronary heart disease through an integrated gene network analysis.
    Dong C; Tang L; Liu Z; Bu S; Liu Q; Wang Q; Mai Y; Wang DW; Duan S
    Gene; 2014 Apr; 539(1):30-6. PubMed ID: 24508273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating and visceral adipose miR-100 is down-regulated in patients with obesity and Type 2 diabetes.
    Pek SL; Sum CF; Lin MX; Cheng AK; Wong MT; Lim SC; Tavintharan S
    Mol Cell Endocrinol; 2016 May; 427():112-23. PubMed ID: 26973292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Obesity, type 2 diabetes, and cancer: the insulin and IGF connection.
    Cohen DH; LeRoith D
    Endocr Relat Cancer; 2012 Oct; 19(5):F27-45. PubMed ID: 22593429
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of vascular endothelial dysfunction genes and related pathways in obesity through systematic bioinformatics.
    Zhang H; Wang J; Sun L; Xu Q; Hou M; Ding Y; Huang J; Chen Y; Cao L; Zhang J; Qian W; Lv H
    Biomed Mater Eng; 2015; 26 Suppl 1():S1871-81. PubMed ID: 26405959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subcutaneous and visceral adipose tissue gene expression of serum adipokines that predict type 2 diabetes.
    Samaras K; Botelho NK; Chisholm DJ; Lord RV
    Obesity (Silver Spring); 2010 May; 18(5):884-9. PubMed ID: 20019678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of gut microbiota in the development of type 1, type 2 diabetes mellitus and obesity.
    Tai N; Wong FS; Wen L
    Rev Endocr Metab Disord; 2015 Mar; 16(1):55-65. PubMed ID: 25619480
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A proteomic approach to obesity and type 2 diabetes.
    López-Villar E; Martos-Moreno GÁ; Chowen JA; Okada S; Kopchick JJ; Argente J
    J Cell Mol Med; 2015 Jul; 19(7):1455-70. PubMed ID: 25960181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.